Meda Pharmaceuticals Overview
- Year Founded
-
2001

- Status
-
Acquired/Merged
- Employees
-
201

- Latest Deal Type
-
M&A
- (Cancelled)
- Financing Rounds
-
4
- Investments
-
1
Meda Pharmaceuticals General Information
Description
Manufacturer of pharmaceutical products in the United States. The company specializes in the manufacturing of pharmaceutical products for respiratory disease, allergy, gastroenterology, rheumatology and other pharmaceutical medicines.
Contact Information
Website
www.medapharma.usCorporate Office
- 265 Davidson Avenue
- Suite 300
- Franklin Township, NJ 08873
- United States
Corporate Office
- 265 Davidson Avenue
- Suite 300
- Franklin Township, NJ 08873
- United States
Meda Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Meda Pharmaceuticals Patents
Meda Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-8895061-B2 | Compositions comprising carisoprodol and methods of use thereof | Active | 02-Mar-2007 | ||
US-20100189782-A1 | Compositions comprising carisoprodol and methods of use thereof | Active | 02-Mar-2007 | ||
CA-2677076-A1 | Compositions comprising carisoprodol and methods of use thereof | Active | 02-Mar-2007 | ||
CA-2677076-C | Compositions comprising carisoprodol and methods of use thereof | Active | 02-Mar-2007 | ||
US-20060241298-A1 | Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof | Inactive | 21-Apr-2005 | C07C271/12 |
Meda Pharmaceuticals Signals
Meda Pharmaceuticals Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Meda Pharmaceuticals Acquisitions (1)
Meda Pharmaceuticals’s most recent deal was a Merger/Acquisition with Wampole Laboratories. The deal was made on 01-May-2001.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Wampole Laboratories | 01-May-2001 | Merger/Acquisition | Laboratory Services (Healthcare) |
Meda Pharmaceuticals Exits (1)
Meda Pharmaceuticals’s most recent exit was on 01-May-2001 from Wampole Laboratories. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Wampole Laboratories | 01-May-2001 | Completed |
|
Meda Pharmaceuticals FAQs
-
When was Meda Pharmaceuticals founded?
Meda Pharmaceuticals was founded in 2001.
-
Where is Meda Pharmaceuticals headquartered?
Meda Pharmaceuticals is headquartered in Franklin Township, NJ.
-
What is the size of Meda Pharmaceuticals?
Meda Pharmaceuticals has 201 total employees.
-
What industry is Meda Pharmaceuticals in?
Meda Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Meda Pharmaceuticals a private or public company?
Meda Pharmaceuticals is a Private company.
-
What is the current valuation of Meda Pharmaceuticals?
The current valuation of Meda Pharmaceuticals is
. -
What is Meda Pharmaceuticals’s current revenue?
The current revenue for Meda Pharmaceuticals is
. -
How much funding has Meda Pharmaceuticals raised over time?
Meda Pharmaceuticals has raised $135M.
-
Who are Meda Pharmaceuticals’s investors?
Ferrer Freeman & Company, Frazier Healthcare Partners, Lightyear Capital, The Carlyle Group, and The Cypress Group have invested in Meda Pharmaceuticals.
-
When was Meda Pharmaceuticals acquired?
Meda Pharmaceuticals was acquired on 27-Aug-2015.
-
Who acquired Meda Pharmaceuticals?
Meda Pharmaceuticals was acquired by Meda.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »